Ayala Pharmaceuticals (NASDAQ:ADXS) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report released on Sunday morning. The firm issued a sell rating on the stock. Ayala Pharmaceuticals Price Performance NASDAQ ADXS opened at $0.03 on Friday. The stock has a market cap of $1.15 million, a PE ratio of 0.00 and a […]
More Stories
Landstar System, Inc. (NASDAQ:LSTR) Shares Acquired by Ameriprise Financial Inc.
Ameriprise Financial Inc. grew its stake in Landstar System, Inc. (NASDAQ:LSTR – Free Report) by 120.7% during the fourth quarter,...
Algert Global LLC Sells 101,687 Shares of Holley Inc. (NYSE:HLLY)
Algert Global LLC decreased its position in shares of Holley Inc. (NYSE:HLLY – Free Report) by 85.3% during the fourth...
BNP Paribas Financial Markets Has $5.37 Million Stock Position in Flex Ltd. (NASDAQ:FLEX)
BNP Paribas Financial Markets trimmed its position in Flex Ltd. (NASDAQ:FLEX – Free Report) by 71.7% in the fourth quarter,...
Ameriprise Financial Inc. Reduces Position in Exelon Co. (NASDAQ:EXC)
Ameriprise Financial Inc. reduced its position in shares of Exelon Co. (NASDAQ:EXC – Free Report) by 12.2% in the 4th...
United Parks & Resorts Inc. (NYSE:PRKS) Shares Bought by Bank of America Corp DE
Bank of America Corp DE lifted its stake in United Parks & Resorts Inc. (NYSE:PRKS – Free Report) by 40.8%...
Bank of America Corp DE Lowers Position in Universal Health Services, Inc. (NYSE:UHS)
Bank of America Corp DE decreased its position in shares of Universal Health Services, Inc. (NYSE:UHS – Free Report) by...